NCT04775264View on ClinicalTrials.gov

Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for AF

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

June 17, 2022

Study Completion Date

April 27, 2023

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Pulsed Electric Field Ablation

Catheter ablation of Ganglionated Plexi (GP) structures on the epicardial surface of the heart during cardiothoracic surgery

Trial Locations (2)

Unknown

Na Homolce Hospital, Prague

Tbilisi Heart & Vascular Clinic, Tbilisi

Sponsors
All Listed Sponsors
lead

Atrian Medical Ltd.

INDUSTRY

NCT04775264 - Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for AF | Biotech Hunter | Biotech Hunter